In this episode, we bring you an interview with Professor Elias Arnér from the Karolinska Institute. After a long international career in redox biology, Professor Arnér became CEO of Thioredoxin Systems, the company behind a potential new antibiotic with a novel target and mode of action: EbsArgent. We explore his background, the lessons he has learned, and what makes this new drug candidate so unique.

In the news section, Elin brings us a recent article on the resistance and potential collateral sensitivity of Ceftazidime-avibactam to treat P. aeruginosa strains. Eva shares the latest publication at our center, with PhD student Adrián González López’s work on the mechanisms behind FusB-mediated resistance in Staphylococcus aureus.

We hope you enjoy this month’s episode, and see you on the next one!

Check relevant links in the show notes here. Follow our updates on ⁠twitter/X & Bluesky⁠ with #theAMRstudio hashtag! Theme music by ⁠Henrik Niss⁠.

Welcome to episode 60th! YES, 60!! Celebrate this rounded number with us and Prof. Till Bachmann in an inspiring interview where we learn Till’s journey, explore how diagnostics are an essential part of managing AMR and infection treatment, and revisit the DOSA project. This multidisciplinary & one-health-focused multi-country endeavor provides solutions to a neglected disease: UTI.

In the news section, we cover a recent review looking at the current uses of AI in the field of AMR and how it can help us better tackle different fronts, like diagnostics, surveillance, or antibiotic development. We also bring you the latest publication by the CARe center in Gothenburg, where they show that an AI model can predict successful horizontal gene transfer leading to resistance, and what drives these events.

We hope you enjoy this episode!

Check relevant links in the show notes here ⁠https://www.uu.se/en/centre/uppsala-antibiotic-center/communication/the-amr-studio/episode-60. Follow our updates on ⁠twitter/X & Bluesky⁠ with #theAMRstudio hashtag! Theme music by ⁠Henrik Niss⁠.

Welcome to a new episode of The AMR Studio! This month, we bring you an interview with MD Dr. Vance Fowler, co-lead of the Antibacterial Resistance Leadership Group (a.k.a. ARLG). In our chat, we learn how Dr. Fowler came into AMR, the decades-long work they’ve been doing with MRSA research, and the ins and outs of the ARLG.

In the news section, we proudly present the recent published paper by our PhD student Valeriia Ladyhina, who has worked on optimizing a pipeline to ease the work to study AMR dynamics in pig farms. We also cover a recent commentary on public involvement for AMR, and an AMR journal collection.

Thank you for being with us one more month!

Check relevant links in the show notes here . Follow our updates on ⁠twitter/X & Bluesky⁠ with #theAMRstudio hashtag! Theme music by ⁠Henrik Niss⁠.

Welcome to 2025! We are so happy to be starting one more year with you, our 8th year! On this episode, we bring you the story and work of Dr. Evangelos Mourkas, a veterinarian-turned-computational biologist who loves to also do the field work himself! In this interview, we dive deep into his motivators, reflections, and how campylobacter can be used as a marker for AMR spread.

On the news section, we bring you a recent paper looking into the potential risks of probiotics through the lens of AMR, and the latest publication by a previous guest, Alvaro San Millán, exploring the cross-talk between plasmids and the carrier’s chromosome.

We hope you enjoy this month’s content and are ready to share an awesome 2025 of learning and exploring new themes!

Check relevant links in the show notes here. Follow our updates on ⁠twitter/X & Bluesky⁠ with #theAMRstudio hashtag! Theme music by ⁠Henrik Niss⁠.

Hitting this November month with a very relevant topic, Global Governance! In this episode, you can listen to an interview with had with Prof. Olivier Rubin, from Roskilde University in Denmark, about the social dimensions of AMR, and how AMR is a so-called “creeping crisis” globally. Olivier has years of experience researching slow-onset crisis such as famine and climate change, and has in the recent years worked intensively in AMR and the similarities and differences with such crises. Tune in to hear his insights!

In the news section, we update you on our very very busy month of November, and bring you a really important paper demonstrating the relationship between rifaximin use and daptomicin resistance in Enterococcus.

Check relevant links in the show notes here. Follow our updates on ⁠twitter/X & Bluesky⁠ with #theAMRstudio hashtag! Theme music by ⁠Henrik Niss⁠.

We are finally back from our looooong break! Welcome, to another episode of The AMR studio, now again with co-host Elin Fermer at the mic after her maternity break. We are so thrilled to bring you our conversation with Eva Krockow, a psychologist working with decision making, risk communications, and language. We learn about her interests and path, and what’s on the pipeline for her.

On the news, we bring you a recent article looking at if the new generation of large language models AI tools such as chat-GPT could be useful to identify resistance, and the most recent pre-print by our interviewee on the use of metaphors in AMR.

We hope you enjoy and are ready for an autumn of goodness, learning and fun at our studio!

Check relevant links in the show notes here https://www.uu.se/en/centre/uppsala-antibiotic-center/communication/the-amr-studio/episode-56. Follow our updates on twitter/X with #theAMRstudio hashtag! Theme music by Henrik Niss.